Role of the galactosyl moiety of collagen glycopeptides for T-cell stimulation in a model for rheumatoid arthritis.

[1]  R. Holmdahl,et al.  Glycopeptide Specificity of Helper T Cells Obtained in Mouse Models for Rheumatoid Arthritis , 2002, Chembiochem : a European journal of chemical biology.

[2]  Antonio Lanzavecchia,et al.  A temporal and spatial summation model for T-cell activation: signal integration and antigen decoding. , 2002, Trends in immunology.

[3]  J. Kihlberg,et al.  An Improved Synthesis of a Galactosylated Hydroxylysine Building Block and its use in Solid-Phase Glycopeptide Synthesis , 2000 .

[4]  J. Kihlberg,et al.  Preparation of a Diglycosylated Hydroxylysine Building Block Used in Solid-Phase Synthesis of a Glycopeptide from Type II Collagen. , 1999, The Journal of organic chemistry.

[5]  L. Fugger,et al.  Transgenic mouse models of rheumatoid arthritis , 1999, Immunological reviews.

[6]  D. Fremont,et al.  High- and low-potency ligands with similar affinities for the TCR: the importance of kinetics in TCR signaling. , 1998, Immunity.

[7]  R. Holmdahl,et al.  Epitope glycosylation plays a critical role for T cell recognition of type II collagen in collagen‐induced arthritis , 1998, European journal of immunology.

[8]  R. Holmdahl,et al.  T Cells Recognize a Glycopeptide Derived from Type II Collagen in a Model for Rheumatoid Arthritis , 1998 .

[9]  L. Fugger,et al.  The structural basis of MHC control of collagen‐induced arthritis; binding of the immunodominant type II collagen 256 – 270 glycopeptide to H‐2Aq and H‐2Ap molecules , 1998, European journal of immunology.

[10]  J. Kihlberg,et al.  Preparation of Tn and sialyl Tn building blocks used in Fmoc solid-phase synthesis of glycopeptide fragments from HIV gp120 , 1997 .

[11]  J. Kamerling,et al.  Synthesis of Hex p-(1 → 4)-β-d-Glc pNAc-(1 → 2)-α-d-Man p-(1 → O)(CH2)7CH3 probes for exploration of the substrate specificity of glycosyltransferases: Part I, Hex = β-d-Gal, 4-deoxy-β-d-Gal, 4-O-methyl-β-d-Gal, 4-deoxy-4-fluoro-β-d-Gal, or β-d-Glc , 1996 .

[12]  J. Howard,et al.  How good is fluorine as a hydrogen bond acceptor , 1996 .

[13]  U. Utz,et al.  Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein , 1996, Nature.

[14]  V. Kuchroo,et al.  An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. , 1995, Immunity.

[15]  L. Szábo,et al.  Stereoselective synthesis of O-serinyl/threoninyl-2-acetamido-2-deoxy-α- or β-glycosides , 1995 .

[16]  R. Holmdahl,et al.  T cell recognition of carbohydrates on type II collagen , 1994, The Journal of experimental medicine.

[17]  R. Holmdahl,et al.  Identification of an immunodominant type‐II collagen peptide recognized by T cells in H‐2q mice: self tolerance at the level of determinant selection , 1992, European journal of immunology.

[18]  R. Holmdahl,et al.  Type II Collagen Autoimmunity in Animals and Provocations Leading to Arthritis , 1990, Immunological reviews.

[19]  A. Kang,et al.  Autoimmunity to type II collagen an experimental model of arthritis , 1977, The Journal of experimental medicine.

[20]  Kendall A. Smith,et al.  Long term culture of tumour-specific cytotoxic T cells , 1977, Nature.

[21]  R. Spiro.  The structure of the disaccharide unit of the renal glomerular basement membrane. , 1967, The Journal of biological chemistry.

[22]  J. Pieters.  MHC class II-restricted antigen processing and presentation. , 2000, Advances in immunology.

[23]  Robin Taylor,et al.  Organic Fluorine Hardly Ever Accepts Hydrogen Bonds , 1997 .

[24]  P. Allen,et al.  Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. , 1996, Annual review of immunology.